Antioxidant, anti-inflammatory or anti-aging composition containing taxus cambium- or procambium-derived cell line as active ingredient
The present invention relates to an antioxidant, anti-inflammatory or anti-aging composition containing any one or more of a Taxus cambium- or procambium-derived cell line, an extract thereof, a lysate thereof and a culture medium thereof. The composition according to the present invention has minimized side effects compared to existing antioxidants and anti-inflammatory agents, is involved in intracellular metabolism to reduce intracellular reactive oxygen species, and reduces and induces aging-related signals. Thus, the composition of the preset invention is useful for preventing and delaying aging. In addition, the composition of the present invention has the effect of inhibiting melanogenesis, and thus is useful as a whitening cosmetic composition.
1. A method of inhibiting inflammation, skin oxidation, and/or skin aging in a subject in need thereof, the method comprising
administering to said subject an effective amount of a composition comprising an extract of a Taxus cell line, wherein the extract is produced by:
(i) dissolving 500 g of a Taxus cambium- or procambium cell line in 500 mL of DMSO with stirring at 50° C. for 6 hours to obtain a dissolved product; and
(ii) centrifuging the dissolved product obtained in step (i) at 3000 g for 10 minutes and collecting the supernatant, wherein the supernatant is said extract.
2. The method according to claim 1 , wherein the cell line has the characteristic that it is in an innately undifferentiated state, separated from the callus formed by dedifferentiation, and is present as single cells during suspension culture.
3. The method according to claim 1 , wherein the cell line is obtained using an isolation method comprising the following steps of:
(a) obtaining a Taxus cambium- or procambium-containing tissue;
(b) culturing the obtained Taxus cambium- or procambium-containing tissue to induce a cambium or procambium layer proliferated from the cambium or procambium and an amorphous callus layer proliferated from tissues other than the cambium or procambium; and
(c) isolating the cambium or procambium layer from the callus layer, and collecting a Taxus cambium- or procambium cell line from the cambium or procambium layer.
4. The method according to claim 3 , wherein the cell line is additionally cultured in a medium, which contains 3-5 wt % of raw sugar or sugar; and/or at least one substance selected from the group consisting of methyl jasmonate, fungal extract, bacterial extract, yeast extract, chitosan, glucomannan, glucan, phenylalanine, benzoic acid, salicylic acid, arachidonic acid, STS, mevalonalonate N-benzolyglycine, ABA, SNP, IPP, BHT, CCC, ethephon, hippuric acid, ammonium ceric nitrate, AgNO 3 , vanadyl sulfate, p-aminobenzoic acid, brassinosteroids, sodium alginate, and sodium acetate.
5. The method according to claim 2 , wherein the cell line is obtained using an isolation method comprising the following steps of:
(a) obtaining a Taxus cambium- or procambium-containing tissue;
(b) culturing the obtained Taxus cambium- or procambium-containing tissue to induce a cambium or procambium layer proliferated from the cambium or procambium and an amorphous callus layer proliferated from tissues other than the cambium or procambium; and
(c) isolating the cambium or procambium layer from the callus layer, and collecting a Taxus cambium- or procambium cell line from the cambium or procambium layer.
6. The method according to claim 5 , wherein the cell line is additionally cultured in a medium, which contains 3-5 wt % of raw sugar or sugar; and/or at least one substance selected from the group consisting of methyl jasmonate, fungal extract, bacterial extract, yeast extract, chitosan, glucomannan, glucan, phenylalanine, benzoic acid, salicylic acid, arachidonic acid, STS, mevalonalonate N-benzolyglycine, ABA, SNP, IPP, BHT, CCC, ethephon, hippuric acid, ammonium ceric nitrate, AgNO 3 , vanadyl sulfate, p-aminobenzoic acid, brassinosteroids, sodium alginate, and sodium acetate.
7. A method of inhibiting inflammation, reducing skin aging and/or reducing wrinkles in a subject in need thereof, the method comprising
applying to said subject an effective amount of a composition comprising an extract of a Taxus cell line, wherein the extract is produced by:
(i) dissolving 500 g of a Taxus cambium- or procambium cell line in 500 mL of DMSO with stirring at 50° C. for 6 hours to obtain a dissolved product; and
(ii) centrifuging the dissolved product obtained in step (i) at 3000 g for 10 minutes and collecting the supernatant, wherein the supernatant is said extract.
8. The method according to claim 7 , wherein the cell line has the characteristic that it is in an innately undifferentiated state, separated from the callus formed by dedifferentiation, and is present as single cells during suspension culture.
9. The method according to claim 8 , wherein the composition inhibits the production of MMP-1.
10. The method according to claim 8 , wherein the cell line is obtained using an isolation method comprising the following steps of:
(a) obtaining a Taxus cambium- or procambium-containing tissue;
(b) culturing the obtained Taxus cambium- or procambium-containing tissue to induce a cambium or procambium layer proliferated from the cambium or procambium and an amorphous callus layer proliferated from tissues other than the cambium or procambium; and
(c) isolating the cambium or procambium layer from the callus layer, and collecting a Taxus species cambium- or procambium cell line from the cambium or procambium layer.
11. The method according to claim 10 , wherein the cell line is additionally cultured in a medium, which contains 3-5 wt % of raw sugar or sugar; and/or at least one substance selected from the group consisting of methyl jasmonate, fungal extract, bacterial extract, yeast extract, chitosan, glucomannan, glucan, phenylalanine, benzoic acid, salicylic acid, arachidonic acid, STS, mevalonalonate N-benzolyglycine, ABA, SNP, IPP, BHT, CCC, ethephon, hippuric acid, ammonium ceric nitrate, AgNO 3 , vanadyl sulfate, p-aminobenzoic acid, brassinosteroids, sodium alginate, and sodium acetate.
12. The method according to claim 7 , wherein the composition inhibits the production of MMP-1.
13. The method according to claim 7 , wherein the cell line is obtained using an isolation method comprising the following steps of:
(a) obtaining a Taxus cambium- or procambium-containing tissue;
(b) culturing the obtained Taxus cambium- or procambium-containing tissue to induce a cambium or procambium layer proliferated from the cambium or procambium and an amorphous callus layer proliferated from tissues other than the cambium or procambium; and
(c) isolating the cambium or procambium layer from the callus layer, and collecting a Taxus species cambium- or procambium cell line from the cambium or procambium layer.
14. The method according to claim 13 , wherein the cell line is additionally cultured in a medium, which contains 3-5 wt % of raw sugar or sugar; and/or at least one substance selected from the group consisting of methyl jasmonate, fungal extract, bacterial extract, yeast extract, chitosan, glucomannan, glucan, phenylalanine, benzoic acid, salicylic acid, arachidonic acid, STS, mevalonalonate N-benzolyglycine, ABA, SNP, IPP, BHT, CCC, ethephon, hippuric acid, ammonium ceric nitrate, AgNO 3 , vanadyl sulfate, p-aminobenzoic acid, brassinosteroids, sodium alginate, and sodium acetate.
15. A method of whitening a skin area of a subject in need thereof, the method comprising applying to the skin area of said subject
an effective amount of a composition comprising an extract of a Taxus cell line, wherein the extract is produced by:
(i) dissolving 500 g of a Taxus cambium- or procambium cell line in 500 mL of DMSO with stirring at 50° C. for 6 hours to obtain a dissolved product; and
(ii) centrifuging the dissolved product obtained in step (i) at 3000 g for 10 minutes and collecting the supernatant, wherein the supernatant is said extract.
16. A method of inhibiting skin aging in a subject in need thereof, the method comprising
orally administering to said subject an effective amount of a composition comprising an extract of a Taxus cell line, wherein the extract is produced by:
(i) dissolving 500 g of a Taxus cambium- or procambium cell line in 500 mL of DMSO with stirring at 50° C. for 6 hours to obtain a dissolved product; and
(ii) centrifuging the dissolved product obtained in step (i) at 3000 g for 10 minutes and collecting the supernatant, wherein the supernatant is said extract.